Investors Watch List : Halozyme Therapeutics, Inc. (NASDAQ:HALO), Yahoo! Inc. (NASDAQ:YHOO), Otter Tail Corporation (NASDAQ:OTTR), Omnicare Inc. (NYSE:OCR), International Business Machines Corporation (NYSE:IBM),

clinical trial of halozyme’s PEGPH20 in combination with modified folfirinox for advanced pancreatic cancer. The company announced that the U.S. Food and Drug Administration or FDA has removed the clinical hold on patient enrollment and dosing of PEGPH20 in SWOG’s ongoing Phase 1b/2 clinical trial (S1313). Halozyme Therapeutics, Inc. (NASDAQ:HALO) belongs to Healthcare sector. Its weekly performance is -1.73%. On last trading day company shares … Continue reading Investors Watch List : Halozyme Therapeutics, Inc. (NASDAQ:HALO), Yahoo! Inc. (NASDAQ:YHOO), Otter Tail Corporation (NASDAQ:OTTR), Omnicare Inc. (NYSE:OCR), International Business Machines Corporation (NYSE:IBM),

Active Stocks: Qualstar Corp. (NASDAQ:QBAK), Halozyme Therapeutics (NASDAQ:HALO), Elizabeth Arden (NASDAQ:RDEN), Saga Communications Inc. (NYSEMKT:SGA), Escalera Resources Co. (NASDAQ:ESCR)

On July 31,2014 Qualstar Corp. (NASDAQ:QBAK), a designer and manufacturer of high efficiency power supplies, as well as data security and archive storage solutions, announced today that it has expanded its AC-DC power supply offerings by adding the high-efficiency slim line DIN Rail Power Supplies to its N2Power brand product portfolio. Qualstar Corp. (NASDAQ:QBAK) belongs to Technology sector. Its net profit margin is -75.70% and … Continue reading Active Stocks: Qualstar Corp. (NASDAQ:QBAK), Halozyme Therapeutics (NASDAQ:HALO), Elizabeth Arden (NASDAQ:RDEN), Saga Communications Inc. (NYSEMKT:SGA), Escalera Resources Co. (NASDAQ:ESCR)

Halozyme Therapeutics, Inc. (NASDAQ:HALO) reported that the U.S. Food and Drug Administration ordered a halt on a study of its drug delivery system in pancreatic cancer patients, barely a week after the company voluntarily stopped the trial. Halozyme Therapeutics, Inc. (NASDAQ:HALO) stock performance was -0.93% in last session and finished the day at $7.42. Traded volume was 3.20million shares in the last session and the … Continue reading Oversold Stocks In News: Halozyme Therapeutics (NASDAQ:HALO), Lumos Networks (NASDAQ:LMOS), Advaxis (NASDAQ:ADXS), Sterling Construction Company (NASDAQ:STRL)

Sales of the Arena Pharmaceuticals Inc (NASDAQ:ARNA) anti-obesity drug Belviq have closed out the quarter on a positive note. Sales improved throughout the quarter and are pacing well ahead of the previous quarter. Though this week’s sales only take us to March 28th, there is enough here for us to assess the sales activity, project some revenue, and look to the pace. Arena Pharmaceuticals, Inc. … Continue reading Biotech Active runners: Arena Pharmaceuticals (NASDAQ:ARNA), Halozyme Therapeutics (NASDAQ:HALO), Gildan Activewear (NYSE:GIL), Ariad Pharmaceuticals (NASDAQ:ARIA)

The only therapy currently approved by the Food and Drug Administration to treat myelofibrosis, a disorder where abnormal blood cells build up inside a patient’s bone marrow, is Incyte (NASDAQ:INCY) and Novartis’ Jakafi (known as Jakavi outside the U.S.), which is a JAK2 inhibitor. JAK2 is an enzyme that plays a key role in signal transduction; therefore, blocking JAK2 can inhibit the development cytokines that … Continue reading Biotech Volatile Stocks: Incyte Corporation (NASDAQ:INCY), Halozyme Therapeutics (NASDAQ:HALO), Sangamo Biosciences (NASDAQ:SGMO), Nektar Therapeutics (NASDAQ:NKTR)

Novavax, Inc. (NASDAQ:NVAX) is a vaccine company that is likely to have multiple milestones this year. It has U.S. government funding for seasonal and pandemic flu, and is developing its own products for respiratory syncytial virus (RSV). Novavax, Inc. (NASDAQ:NVAX) stock performance was -5.02% in last session and finished the day at $6.05. Traded volume was 4.36million shares in the last session and the average … Continue reading Biotech Losers: Novavax (NASDAQ:NVAX), Achillion Pharmaceuticals (NASDAQ:ACHN), The Clorox (NYSE:CLX), Halozyme Therapeutics (NASDAQ:HALO)